5-HT(1A) receptor hypersensitivity in migraine is suggested by the m- chlorophenylpiperazine test

NeuroReport

Volumn 9, Issue 11, 1998, Pages 2605-2608

  Leone, Massimo ^a   Attanasio, Angelo ^a   Croci, Danilo ^a   Ferraris, Alessandra ^a   D'Amico, Domenico ^a   Grazzi, Licia ^a   Nespolo, Angelo ^a   Bussone, Gennaro ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Anxiety; m Chlorophenylpiperazine; Migraine; Pathogenesis; Prolactin; Serotonin; Stress

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; PROLACTIN; SEROTONIN; SEROTONIN 1A RECEPTOR; 1-(3-CHLOROPHENYL)PIPERAZINE; DIAGNOSTIC AGENT; HYDROCORTISONE; PIPERAZINE DERIVATIVE; SEROTONIN 1 RECEPTOR; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXPECTATION; FEMALE; HUMAN; MALE; MIGRAINE; NEUROMODULATION; NEUROPATHOLOGY; PRIORITY JOURNAL; PROLACTIN RELEASE; RECEPTOR SENSITIVITY; SEROTONIN METABOLISM; BLOOD; CHEMICALLY INDUCED DISORDER; METABOLISM; PSYCHOLOGICAL ASPECT;

ADULT; ANXIETY; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIGRAINE DISORDERS; PIPERAZINES; PROLACTIN; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS;

EID: 0032479593     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199808030-00033     Document Type: Article

References (26)

1. Ferrari MD and Saxena PR. Cephalalgia 13, 151-165 (1993).
2. Raskin NH, Hosobuchi Y and Lamb S. Headache 27, 416-420 (1987).
3. Panconesi A and Sicuteri R. Cephalalgia 17, 3-14 (1997).
4. Kalkman HO. Life Sci 54, 641-644 (1994).
5. Martin GR. Cephalalgia 17 (Suppl 18), 4-14 (1997).
6. Fozard JR. 5-Hydroxytryptamine and nitric oxide: the causal relationship between two endogenous precipitants of migraine. In: Sandler M, Ferrari M and Harnett S, eds. Migraine: Pharmacology and Genetics. London: Chapman and Hall, 1996: 167-179.
7. Eide PK and Hole K. Cephalalgia 13, 75-85 (1993).
8. Fiorella D, Rabin RA and Winter JC. Psychopharmacology 119, 222-230 (1995).
9. Murphy DL. Mueller EA, Hill JI et al. Psychopharmacology 98, 275-282 (1989)
10. Headache Classification Committee of the International Headache Society (IHS). Cephalalgia 8 (Suppl 7) (1988).
11. Suckow RF, Cooper TB and Kahn RS. J Chromatogr 528, 228-234 (1990).
12. Gordon ML, Lipton RB, Brown SL et al. Cephalalgia 13, 399-405 (1993).
13. Bagdy G and Makara GB. Eur J Pharmacol 275, 301-305 (1995).
14. Meltzer MY and Maes M. Psychopharmacology 114, 635-643 (1994).
15. Lee MA, Nash JF, Barnes M and Meltzer HY. Psychopharmacology 103, 258-264 (1991).
16. Buchwalder A, Welch SK and Peroutka SJ. Headache 36, 254-258 (1996).
17. Awaki E, Takeshima T and Takahashi K. Cephalalgia 9, 187-193 (1989).
18. Papakostas Y, Daras M, Markianos M and Stefanis C. J Neurol Neurosurg Psychiatry 50, 927-928 (1987).
19. Merikangas KR and Stevens DE. Adv Headache 15, 115-123 (1997).
20. Kahn RS and Weltzer S. Biol Psychiatry 30, 1139-1166 (1991).
21. Leone M, Attanasio A, Croci D et al. Ital J Neurol Sci 18, 46 (1997).
22. Leone M, Attanasio A, Croci D et al. Cephalalgia 17, 666-672 (1997).
23. Leone M, Attanasio A, Grazzi L et al. J Neurol Sci 150 (suppl. Sept), S303.
24. Hoyer D, Clarke DE, Fozard JR et al. Pharmacol Rev 46, 157-203 (1994).
25. Coccaro EF, Gabriel S and Siever LJ. Psychopharmacol Bull 26, 393-405 (1990).
26. Hsieh JC, Støhle-Bäckdahl M, Hägermark ö et al. Pain 64, 303-314 (1995).